Atrial natriuretic peptide (ANP) has unique effects on the renal vascu
lature, in that it dilates preglomerular vessels and constricts effere
nt arterioles. In the present study we aimed to characterize the natri
uretic peptide receptor (NPR) subtypes, which mediate the renovascular
effects of ANP, using in vivo microscopy in the split hydronephrotic
kidney model of rats, ANP (10(-9) and 3.10(-9)), which binds to NPR-A
and NPR-C, dilated preglomerular vessels and constricted efferent arte
rioles similarly to that found in previous studies. C-type natriuretic
peptide (10(-9) to 10(-7)), which binds to NPR-B and NPR-C, dilated p
re- and postglomerular vessels and profoundly increased glomerular blo
od Bow. A specific ligand of NPR-C, C-ANP (des-[Gln(18),Ser(19),Gly(20
),Leu(21), Gly(22)]ANP(4-23)-NH2, 10(-9) to 10(-7)) was devoid of vasc
ular effects. The ANP antagonist A71915 (10(-9) to 10(-6)) induced mod
erate dilation in renal vessels possibly due to some agonistic activit
y on NPR-B. ANP-induced preglomerular vasodilation was attenuated by A
71915 (10(-6)) to 36 +/- 6% of the initial response, whereas efferent
vasoconstriction was completely abolished (-4 +/- 4% of initial respon
se). Our results indicate that ANP dilates preglomerular vessels and c
onstricts efferent arterioles through NPR-A, both responses being anta
gonized by A71915 with different potencies. Furthermore, our data show
that in the rat renal microcirculation stimulation of NPR-B results i
n vasodilation only, whereas NPR-C does not mediate vascular responses
.